glp 1 and eyes GLP-1 Meds Reduce Risk of Uveitis GLP-1 medications have soared in

Under standard timelines, that takes more than a year

The latest diabetic retinopathy preferred practice guidelines from the American Academy of Ophthalmology indicate that the rising use of GLP-1RAs may lead to quick glycemic control and severe hypoglycemia and has been reported to cause higher rates of retinopathy complications, especially in patients with early-stage DR (Lim et al., 2025)

Growth hormone-releasing peptides (GHRPs) and GHRH analogs like CJC1295 are prohibited at all times under S2 class substances. World Anti-Doping Agency (WADA) Athletes in sanctioned sports should avoid use unless under physician supervision and within TUE (Therapeutic Use Exemption) protocol guidelines

As in the case of the injectable GLP-1RAs, these side effects were generally mild to moderate and occurred during dose escalation and were generally transient and mitigated by gradual dose escalation

doi: 10.1016/j.rbmo.2014.02.011 98 ZhouLQuHYangLShouL